Valeant: Big Trouble in Big Pharma

Shares in the drug company accused of price gouging just fell 51% in one day. Someone fetch the violin.

by Adam Gale
Credit: Victor/Flickr
Credit: Victor/Flickr

Chief executives shouldn’t obsess about the share price. Trading is a game, after all, and stock a swinging speculative asset that often doesn’t reflect the underlying growth or profitability of a business. But when your share price chart looks like this, it’s probably time to start paying attention.


Canadian pharmaceutical ex-giant Valeant is rapidly turning into Mike Teevee, the incredible shrinking boy from Roald Dahl’s Charlie and the Chocolate Factory. Except Roald Dahl’s Mike eventually stopped shrinking – the same may not be said for Valeant. The company’s stock fell 51% yesterday, and it’s 86% down from where it was in September. Roughly speaking, that’s $70bn (£50bn) of shareholder value that’s been sluiced in six months.   

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8121



  • Up to 4 free articles a month
  • Free email bulletins

Register Now

Become a subscriber

From £66 a quarter

  • Full access to
  • Exclusive event discounts
  • Management Today's print magazine
  • Plus lots more, including our State of the Industry Report.

Choose a Package